Universal CAR-NK for relapsed/refractory B-cell lymphoma, 3/6 cases achieved CR
Universal CAR-NK for relapsed/refractory acute myeloid leukemia (AML), 3/5 cases achieved CR
Lancet Haematol: Jin Jie / Zhu Honghu team used Veneclax + DA regimen to treat AML, the first CR was as high as 91%
AACR 2022: 100% CR rate in 3 months!
Br J Cancer: Effects of BRAF, KRAS and MSI on cytoreductive surgery (CRS) and hyperthermic
cardiac arrest: decreased total NAA/CR and increased LAC/CR, increasing the risk of irreversible!
Oncolytic virus CG0070 achieves 100% CR in high-risk bladder cancer patients Domestic Lepu Biotech has obtained clinical approval
Cases Shenghui | MSI-H advanced colon cancer patients achieved CR after 1 year of nvolizumab treatment!
The oncolytic virus CG0070 achieves 100% CR in high-risk bladder cancer patients, and the domestic Lepu Biologics has obtained clinical approval
【OC Archives】Combined with a variety of underlying diseases, Nirapali decisively started to provide
[2021 ASH] APG-2575, a selective inhibitor of Bcl-2, was selected for two studies, and the Chinese clinical study showed CR
Professor Han Weidong interviewed to quell CRS, tocilizumab escorted CAR-T precision treatment
CR reached within 6 weeks of treatment, and the total diameter of the target lesion was reduced
GM-CSF: The new favorite of rheumatism immunity, the new crown CRS will be approved soon
Petrochemical Machinery Passed the Verification of National Science and Technology Major Special Archives
GM-CSF monoclonal antibody combined with Yescarta, all CRS events are less than or equal to grade 3!
Flt3 inhibitor AML produces CR: talk about off-target...
Flt3 inhibitor AML produces CR: talk about off-target activity
Case Sharing|To live up to the "Tuo", Tuoyi treats nasopharyngeal carcinoma with high risk of recurrence and metastasis up to CR!
The first show of Guangdong Congress (Part 1): True and false CR after ALK-positive lung adenocarcinoma targeted therapy